Chlorek benzalkoniumu do formuł trądzikowych bez antybiotyków

As part of our ongoing collaboration with Novo Nordisk Pharmatech, we are pleased to share new application insights exploring the use of Benzalkonium Chloride (BKC) in modern acne formulations. As one of our key principals, Novo Nordisk Pharmatech continues to develop high-quality, pharmacopeial-grade ingredients supported by robust technical research.

The shift towards antibiotic-free acne treatments

The development of modern acne treatments increasingly focuses on effective antimicrobial performance without relying on antibiotics. With rising concerns about antibiotic resistance and biofilm-related treatment failure, formulators are exploring alternative actives that can support safe and effective topical products.

Why Benzalkonium Chloride (BKC)?

Benzalkonium Chloride (BKC) is a well-known antimicrobial compound widely used in pharmaceutical formulations. Manufactured under pharmacopeial standards, BKC offers broad-spectrum antimicrobial activity and compatibility with a wide range of topical formulations.

Application study: BKC in semi-solid formulations

Recent application research from Novo Nordisk Pharmatech explores the potential of low concentrations of BKC in semisolid acne formulations.

In the study, hydroxyethyl cellulose (HEC) gel formulations containing 0.03%, 0.06% and 0.13% BKC were evaluated against several acne-related microorganisms, including:

Cutibacterium acnes
Staphylococcus aureus
MRSA
Staphylococcus epidermidis

Results demonstrated rapid antimicrobial efficacy, achieving reductions of ≥4.5–5 log₁₀ within two hours — even at the lowest BKC concentration.

Stability and formulation reliability

To support formulation reliability, BKC content and stability were confirmed using a modified USP HPLC method, ensuring consistent potency over time.

Skin compatibility for daily use

Dermal tolerability was also evaluated using an ISO-standard irritation study. Low BKC concentrations demonstrated good skin compatibility comparable to a benzoyl peroxide control, highlighting the suitability of BKC for daily topical use.

Supporting next-generation acne formulations

These results demonstrate how Benzalkonium Chloride may support the development of antibiotic-free acne treatments with strong antimicrobial performance and favorable skin tolerability.

For more detailed results and formulation insights, download the full application note from Novo Nordisk Pharmatech.